Actinium Pharmaceuticals Inc. Watch

from 10-Q 2 pages Amendment to Employment Agreement

from 8-K 2 pages Fourth Amendment to Actinium Pharmaceuticals, Inc. 2019 Stock Plan

from 10-Q 14 pages Agreement of Sublease Between Abn Amro Holding USA LLC as Sublandlord and Actinium Pharmaceuticals, Inc. as Subtenant Premises: Entire 23rd Floor 100 Park Avenue New York, New York 10017 Agreement of Sublease

from 10-Q 46 pages Exclusive License and Supply Agreement

from 8-K 1 page Second Amendment to Actinium Pharmaceuticals, Inc. 2019 Plan

from 8-K 1 page Amendment to Actinium Pharmaceuticals, Inc. 2019 Plan

from 8-K 14 pages Actinium Pharmaceuticals, Inc. 2019 Stock Plan

from 10-Q 8 pages (A) You Shall Continue to Serve as Chief Medical Officer. You Shall Report to the Chief Executive Officer or Appropriate Company Officer, as Designated by the CEO, the Board of Directors of the Company (The “Board”) or Its Representative, and Shall Perform Your Duties for the Company at the Company’s Offices in New York City, or at Another Location as Directed by the Company in Accordance With Its Policies That May Be in Place From Time to Time, Except for Travel That May Be Necessary or Appropriate in Connection With the Performance of Your Duties Hereunder. the Offices of the Company Are Currently Located in New York City at 275 Madison Avenue, 7th Floor, New York, Ny 10016. (B) You Agree to Devote Your Best Efforts and Substantially All of Your Business Time to Advance the Interests of the Company and to Discharge Adequately Your Duties Hereunder. 2. Compensation. (A) Base Salary. the Board Shall Review the Amount of Your Base Salary and Performance Bonus, and Shall Determine the Appropriate Adjustments to Each Component of Your Compensation Each Calendar Year

from 10-Q 8 pages (A) You Shall Serve as Chief Scientific and Technology Officer. You Shall Report to the Chief Executive Officer or Appropriate Company Officer, as Designated by the CEO, the Board of Directors of the Company (The “Board”) or Its Representative, and Shall Perform Your Duties for the Company at the Company’s Offices in New York City, or at Another Location as Directed by the Company in Accordance With Its Policies That May Be in Place From Time to Time, Except for Travel That May Be Necessary or Appropriate in Connection With the Performance of Your Duties Hereunder. the Offices of the Company Are Currently Located in New York City at 275 Madison Avenue, 7th Floor, New York, Ny 10016. (B) You Agree to Devote Your Best Efforts and Substantially All of Your Business Time to Advance the Interests of the Company and to Discharge Adequately Your Duties Hereunder. 2. Compensation. (A) Base Salary. the Board Shall Review the Amount of Your Base Salary and Performance Bonus, and Shall Determine the Appropriate Adjustments to Each Component of Your Compensation Each Calendar Year

from 10-Q 8 pages (B) You Agree to Devote Your Best Efforts and Substantially All of Your Business Time to Advance the Interests of the Company and to Discharge Adequately Your Duties Hereunder. You May Perform Certain Consulting Projects That Do Not Interfere With Your Company Duties and Maintain Whatever Licenses Required for Performance of Such Consulting Activities. Consulting Activities Must Be Non-Competitive With the Company’s Plans, Disclosed and Approved on a Case by Case Basis by Your Direct Supervisor or an Authorized Company Representative. 2. Compensation. (A) Base Salary. the Board Shall Review the Amount of Your Base Salary and Performance Bonus, and Shall Determine the Appropriate Adjustments to Each Component of Your Compensation Each Calendar Year

from 10-Q 12 pages On Behalf of Actinium Pharmaceuticals, Inc. (The “Company”), I Am Pleased to Provide You With This Contract (The “Agreement”) Related to Your Position as Chief Executive Officer and Chairman of the Board of the Company. This Agreement Replaces Your Employment Agreement With the Company Dated August 8, 2018 (“Prior Agreement”). This Agreement Sets Forth the Terms Related to Your Position as Chief Executive Officer and Chairman of the Board of the Company. 1. Position. the Terms of Your Position With the Company Are as Set Forth Below

from 10-Q 2 pages Amendment to Warrant to Purchase Common Stock of Actinium Pharmaceuticals, Inc

from 8-K 35 pages Securities Purchase Agreement

from 10-K 1 page Amendment No. 7 to Actinium Pharmaceuticals, Inc. 2013 Amended and Restated Stock Plan

from 10-K 45 pages Actinium Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) Amended and Restated at Market Issuance Sales Agreement

from 10-K 9 pages Consulting Agreement Effective Date: December 22, 2019

from 8-K 14 pages Registration Rights Agreement

from 8-K 50 pages Purchase Agreement

from 10-Q 5 pages (B) You Agree to Devote Your Best Efforts and Substantially All of Your Business Time to Advance the Interests of the Company and to Discharge Adequately Your Duties Hereunder. You May Perform Certain Consulting Projects That Do Not Interfere With Your Company Duties and Maintain Whatever Licenses Required for Performance of Such Consulting Activities. Consulting Activities Must Be Non-Competitive With the Company’s Plans, Disclosed and Approved on a Case by Case Basis by Your Direct Supervisor or an Authorized Company Representative. 2. Effective Date. the Effective Date of This Agreement Is August 8, 2018. 3. Proof of Right to Work. for Purposes of Federal Immigration Law, You Provided to the Company Documentary Evidence of Your Identity and Eligibility for Employment in the United States. 4. Compensation. (A) Base Salary. the Board Shall Review the Amount of Your Base Salary and Performance Bonus, and Shall Determine the Appropriate Adjustments to Each Component of Your Compensation Each Calendar Year

from 10-Q 11 pages On Behalf of Actinium Pharmaceuticals, Inc. (The “Company”), I Am Pleased to Provide You With This Contract (The “Agreement”) Related to Your Position as Chief Executive Officer and Chairman of the Board of the Company. This Agreement Replaces Your August 6, 2015 Executive Chairman Agreement (“Prior Agreement”), as Amended. This Agreement Sets Forth the Terms Related to Your Position as Chief Executive Officer and Chairman of the Board of the Company While Retaining and Adapting Material Provisions of the Prior Agreement to That of Your Role of Chief Executive Officer. 1. Position. the Terms of Your Position With the Company Are as Set Forth Below